Published on
Are cancer patients at risk for second cancers? Yes, according to Dr. Thomas Martin, a myeloma expert at UCSF Medical Center. Dr. Martin discusses when incidences tend to increase and whether they may be correlated to therapy.
View more programs featuring Thomas Martin, MD
Produced in association with Multiple Myeloma Opportunities for Research and Education (MMORE)
Become a member to access our latest content and be the first to know about new programs and information.
Myeloma patients are at higher risk for secondary cancers. Dr. Meletios Dimopoulos talks about what you and your doctor can do to keep that risk as low as possible.
Published:
Receiving the news that the Hodgkin Lymphoma relapsed can be devastating and cause a feeling of uncertainity especially when more aggressive treatments and medications are required.
Published:
It’s a time of great progress in developing new medicines for myeloma, but according to patient advocate Eric Low, it's important to be respectful and honest about expectations. Hear him explain his measured view of hope.
Published:
